Búsqueda | Biblioteca Virtual en Salud

1.

Development of a new controlled-release formulation of chlorpheniramine maleate using in vitro/in vivo correlations.

Williams, R L; Upton, R A; Ball, L; Braun, R L; Lin, E T; Liang-Gee, W; Leeson, L J.

J Pharm Sci ; 80(1): 22-5, 1991 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-2013843

2.

Product dissolution methods.

Leeson, L J.

J Pharm Sci ; 62(4): IV, 1973 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-4699003

3.

Significance of dissolution standards.

Leeson, L J.

J Pharm Sci ; 62(9): VI, 1973 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-4743126

4.

Some observations on nonlogarithmic titration curves for the determination of dissociation constants and purity.

Leeson, L J; Brown, M.

J Pharm Sci ; 55(4): 431-3, 1966 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-5960297

5.

Stability of tetracycline and riboflavin.

Leeson, L J; Weidenheimer, J F.

J Pharm Sci ; 58(3): 355-7, 1969 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-5782032

6.

Protection of oxygen-sensitive pharmaceuticals with nitrogen.

Brown, M; Leeson, L J.

J Pharm Sci ; 58(2): 242-5, 1969 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-5779870

7.

Calculating absorption rate constants for drugs with incomplete availability.

Leeson, L J; Weintraub, H.

J Pharm Sci ; 62(12): 1936-41, 1973 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-4762161

8.

The in vitro development of extended-release solid oral dosage forms.

Leeson, L J; Adair, D; Clevenger, J; Chiang, N.

J Pharmacokinet Biopharm ; 13(5): 493-514, 1985 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-3834065

9.

The objective and timing of drug disposition studies, appendix IV. Phenylbutazone formulations: in vitro dissolution and in vivo performance.

Leeson, L J; Shinal, E C; Lukas, G; Zak, S B; Weiner, M.

Drug Metab Rev ; 4(2): 277-84, 1975.

Artículo en Inglés | MEDLINE | ID: mdl-1222684

10.

Oros controlled-release formulations of metoprolol: an approach to the development of a system for once daily administration.

Good, W; Leeson, L J; Zak, S L; Wagner, W E; Meeker, J B; Arnold, J D.

Br J Clin Pharmacol ; 19 Suppl 2: 231S-238S, 1985.

Artículo en Inglés | MEDLINE | ID: mdl-4005128

11.

The development of USP dissolution and drug release standards.

Cohen, J L; Hubert, B B; Leeson, L J; Rhodes, C T; Robinson, J R; Roseman, T J; Shefter, E.

Pharm Res ; 7(10): 983-7, 1990 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-2281043

12.

Phenotypic differences in dextromethorphan metabolism.

Vetticaden, S J; Cabana, B E; Prasad, V K; Purich, E D; Jonkman, J H; de Zeeuw, R; Ball, L; Leeson, L J; Braun, R L.

Pharm Res ; 6(1): 13-9, 1989 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-2717511

13.

Phenylbutazone.

Leeson, L J.

Pharmacology ; 8(1): 154-63, 1972.

Artículo en Inglés | MEDLINE | ID: mdl-4644645

14.

A better way to present posters.

Leeson, L J; Levy, G.

Pharm Res ; 7(5): 561, 1990 May.

Artículo en Inglés | MEDLINE | ID: mdl-1973291

Biblioteca Virtual en Salud

Hipertensión

Su selección (0)

Formato de exportación:

Exportar:

Development of a new controlled-release formulation of chlorpheniramine maleate using in vitro/in vivo correlations.

Product dissolution methods.

Significance of dissolution standards.

Some observations on nonlogarithmic titration curves for the determination of dissociation constants and purity.

Stability of tetracycline and riboflavin.

Protection of oxygen-sensitive pharmaceuticals with nitrogen.

Calculating absorption rate constants for drugs with incomplete availability.

The in vitro development of extended-release solid oral dosage forms.

The objective and timing of drug disposition studies, appendix IV. Phenylbutazone formulations: in vitro dissolution and in vivo performance.

Oros controlled-release formulations of metoprolol: an approach to the development of a system for once daily administration.

The development of USP dissolution and drug release standards.

Phenotypic differences in dextromethorphan metabolism.

Phenylbutazone.

A better way to present posters.